Does LEVOKETOCONAZOLE Cause Upper respiratory tract infection? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Upper respiratory tract infection have been filed in association with LEVOKETOCONAZOLE (Recorlev). This represents 1.6% of all adverse event reports for LEVOKETOCONAZOLE.
5
Reports of Upper respiratory tract infection with LEVOKETOCONAZOLE
1.6%
of all LEVOKETOCONAZOLE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Upper respiratory tract infection From LEVOKETOCONAZOLE?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Upper respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOKETOCONAZOLE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOKETOCONAZOLE Cause?
Nausea (108)
Fatigue (106)
Headache (84)
Vomiting (68)
Diarrhoea (45)
Dizziness (42)
Malaise (40)
Weight decreased (38)
Pain (37)
Arthralgia (36)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which LEVOKETOCONAZOLE Alternatives Have Lower Upper respiratory tract infection Risk?
LEVOKETOCONAZOLE vs LEVOLEUCOVORIN
LEVOKETOCONAZOLE vs LEVOMEPROMAZINE
LEVOKETOCONAZOLE vs LEVOMETHADONE
LEVOKETOCONAZOLE vs LEVOMILNACIPRAN
LEVOKETOCONAZOLE vs LEVONORGESTREL